Advanced Research and Invention Agency (ARIA)’s new Activation Partners in the agency’s Scalable Neural Interfaces opportunity space, aims to rocket-boost progress on a new generation of neuro-technologies designed to treat conditions such as depression, dementia, chronic pain, epilepsy and injuries to the nervous system.
Meet the partners:
Cambridge University Health Partners
Cambridge University Health Partners (CUHP) is one of eight Academic Health Science Centres in England whose mission is to improve patient healthcare by bringing together the NHS, industry and academia. Along with leaders from across the Cambridge life sciences and healthcare ecosystem, CUHP devised and now implements the life science strategy for the Cambridge region. The partners are, Anglia Ruskin University (ARU), Cambridge and Peterborough NHS Foundation Trust, Cambridge University Hospitals NHS Foundation Trust, Royal Papworth Hospital NHS Foundation Trust and the University of Cambridge.
The Babraham Research Campus
The Babraham Research Campus is a leading location which supports early-stage bioscience enterprise and is distinct in its co-location of bioscience companies with the world leading discovery research of the Babraham Institute. Our Campus is a dynamic environment within 430 acres of parkland, home to over 60 companies, 2,000 employees and 300 academic researchers.
Cambridgeshire and Peterborough NHS Foundation Trust
Cambridgeshire and Peterborough NHS Foundation Trust (CPFT) is a health and social care organisation providing integrated community care including mental health and specialist learning disability services across Cambridgeshire and Peterborough, and children’s community services in Peterborough.
Cambridge Network
Cambridge Network is a not-for-profit membership organisation that brings people together from business and academia to exchange ideas, foster collaboration and build partnerships for shared success. Through networking, events, training and recruitment services, it connects and supports businesses, sparking collaboration within its vibrant network of members.
Cambridge Neuroscience
Cambridge Neuroscience is a virtual Interdisciplinary Research Centre at the University of Cambridge. It serves to connect ~900 neuroscientists across all 6 schools of the university with membership spanning more than 30 Departments and affiliated institutions. Cambridge Neuroscience connects people, facilitates interdisciplinary research, and supports the University's mission, which is to contribute to society through the pursuit of education, learning and research at the highest levels of excellence.
The University of Cambridge Departments of Engineering and Psychiatry
The University of Cambridge is one of the world’s leading universities, with a rich history of radical thinking dating back to 1209. Its mission is to contribute to society through the pursuit of education, learning and research at the highest international levels of excellence. The University comprises 31 autonomous Colleges and over 100 departments, faculties and institutions. Cambridge research spans almost every discipline, from science, technology, engineering and medicine through to the arts, humanities and social sciences, with multi-disciplinary teams working to address major global challenges.
The Milner Therapeutics Institute
The Milner Therapeutics Institute (MTI) encompasses both a research institute and a global outreach programme, which aims to transform pioneering science into therapies. The MTI is breaking new ground in academic/industry interactions and demonstrates a world-leading model of start-up companies, academics and pharma working side by side at the bench. The Institute houses its own research teams, the Frame Shift Bio-incubator, and the Functional Genomics Screening Laboratory.
The Maxwell Centre
The Maxwell Centre is the centrepiece of academia-industry engagement at the University of Cambridge, actively interfacing leading research in Physical Sciences and Technology with industry and catalysing impactful innovation. The Maxwell Centre has been driving interdisciplinary interactions and collaborations with companies in Cambridge since 2016, aligning and connecting expertise to co-develop solutions within strategic challenge areas.
Vellos
Vellos, co-founded by Prof Sir Tony Kouzarides - who also co-founded Abcam and the Milner Therapeutics Institute - is dedicated to advancing life science innovation through company creation. It promotes impact at research institutions by empowering entrepreneurship and drives innovation through the creation of world-class ventures.